Covestor LTD Roivant Sciences Ltd. Transaction History
Covestor LTD
- $160 Million
- Q4 2024
A detailed history of Covestor LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Covestor LTD holds 20,634 shares of ROIV stock, worth $221,609. This represents 0.15% of its overall portfolio holdings.
Number of Shares
20,634
Previous 19,190
7.52%
Holding current value
$221,609
Previous $222,000
10.36%
% of portfolio
0.15%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$707 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$666 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$513 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$473 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$380 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.57B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...